share_log

Brooklyn ImmunoTherapeutics | 10-K: FY2021 Annual Report

SEC ·  Apr 15, 2022 17:07
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more